Exceed Orphan
  • Company
    • About
    • Team
    • Your Pharma Partner in Europe
  • Solution
    • Market access coordination
    • Marketing and sales
    • Market research and analysis
    • Medical and pre-marketing activities
    • Regulatory, PV and Distribution
  • News
  • Contact
  • Sign in
  • Sign out
Exceed Orphan

Experts for Orphan Drugs
in Central & Eastern Europe

  • Exceed Orphan
  • Solution
    • Market access coordination
    • Market research and analysis
    • Medical and pre-marketing activities
    • Marketing and sales
    • Regulatory, PV and Distribution
  • News
    • #genetherapy
    • #cooperation
    • #news
  • Company
    • About
    • Team
  • Contact

News

#blog #cooperation #genetherapy #news
All news
May 9, 2022
  • #news

ExCEEd Orphan announces partnership with SERB to exclusively distribute Voraxaze® and DigiFab® in Central and Eastern Europe (CEE)

Under the terms of the agreement, ExCEEd Orphan will have exclusive rights to

Read more
May 4, 2022
  • #news

ExCEEd Orphan announces opening of the third non-EU affiliate in Albania

The ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions

Read more
March 9, 2022
  • #news

ExCEEd Orphan announces partnership with Proveca Pharma Ltd to commercialise and distribute Sialanar® exclusively in Central and Eastern Europe (CEE)

Under the terms of the agreement, ExCEEd Orphan will have exclusive rights to

Read more
February 1, 2022
  • #news

First sales of ProPrems in the CEE region

„ExCEEd Orphan and Neobiomics are happy to announce the first sales of ProPrems®

Read more
February 1, 2022
  • #news

ExCEEd Orphan announces new members of the team in Adriatic Region

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in

Read more
December 7, 2021
  • #news

ExCEEd Orphan announces signature of an exclusive Distribution Agreement with Advicenne for marketing and distribution of Sibnayal® in Central and Eastern Europe

ExCEEd Orphan Distribution d.o.o., a Croatia based fully-owned subsidiary of ExCEEd Orphan s.r.o.,

Read more
November 29, 2021
  • #news

ExCEEd Orphan announces opening of the next non-EU affiliate in North Macedonia

The ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions

Read more
November 16, 2021
  • #news

ExCEEd Orphan and World Orphan Drug Congress in Barcelona

“During upcoming World Orphan Drug Congress in Barcelona (https://www.terrapinn.com/conference/world-orphan-drug-congress/agenda.stm), Jiri Hermanek, CEO of ExCEEd Orphan (https://www.exceedorphan.com/)

Read more
November 1, 2021
  • #news

ExCEEd Orphan Announces Signature of an Exclusive Distribution Agreement with Mirum Pharmaceuticals for Marketing and Distribution of LIVMARLI™ (maralixibat) in Central and Eastern Europe

ExCEEd Orphan Distribution d.o.o., a Croatia based fully-owned subsidiary of ExCEEd Orphan s.r.o.,

Read more
Older news
ExceedOrphan - logo - greyscale
  • Solution
    • Solution
  • Resources
    • Partners area
    • News
  • Company
    • About
    • Team
  • Contact
    • Contact
  • Partners
    • Sign in

© 2020 ExCEEd Orphan

  • GDPR
  • Code of ethics